Personalized Medicine’s 20th Anniversary: From Promise to Practice
November 30 – December 1, 2023 • Ritz-Carlton Laguna Niguel, Dana Point, CA
Use the links below to find detailed information about previous iterations of the Annual Personalized Medicine Conference.
16th Annual Personalized Medicine Conference
The 16th Annual Personalized Medicine Conference facilitated a cross-sector exchange of perspectives on the scientific, business, and policy issues influencing the status and outlook for personalized medicine in the wake of the devastating Covid-19 pandemic. Participants helped chart a course toward a brighter future for patients and health systems.
Video recordings and transcripts of key conference sessions are available upon request.
15th Annual Personalized Medicine Conference
Featuring a keynote address from former FDA commissioner Dr. Scott Gottlieb as well as fireside chats with the University of Pennsylvania’s Dr. Carl June/Dr. Stephen L. Eck of Immatics US and Johnson & Johnson’s Dr. Paul Stoffels/CNBC Reporter Meg Tirrell, The 15th Annual Personalized Medicine Conference: The Paradigm Evolves examined how ongoing genetic discoveries as well as groundbreaking molecular diagnostics augmented by artificial intelligence, advanced data analytics, and digital health applications are empowering both physicians and patients with information about how an expanded set of biological characteristics may influence their health and their responses to various therapies. Health systems, they concluded, will need to adapt their practices, processes, and policies to ensure that patients benefit from these powerful new opportunities.
14th Annual Personalized Medicine Conference
Participants in the 14th Annual Personalized Medicine Conference: Preparing for the New Possible examined the infrastructure and business strategies necessary to overcome scientific obstacles, optimize public policies, and change embedded medical norms as we sought to accelerate investment in and adoption of personalized medicine. They concluded that the speed at which health systems around the world integrate new tools to realize the benefits of targeting increasingly impactful personalized treatments to only those patients who will benefit will depend largely on decision-makers’ willingness to put in place supportive regulatory and reimbursement policies; prioritize studies about the clinical and economic utility of personalized health care; and adopt innovative reimbursement approaches that facilitate sustainable access to therapies that translate higher up-front costs into a more effective and efficient health system.
13th Annual Personalized Medicine Conference
Participants in the 13th Annual Personalized Medicine Conference: From Concept to the Clinic concluded that tackling the emerging challenges associated with commercializing diagnostics, evaluating therapies and personalizing clinical care will require innovative partnerships. They noted, for example, that in 2017 a diagnostic company had teamed up with three different pharmaceutical companies to secure regulatory approval for a next-generation sequencing test; a drug company had collaborated with a health insurance company on a risk-sharing payment agreement in which the company pays for a personalized drug only when the drug works; and several clinical institutions had collaborated with an IT company to organize a data-sharing initiative that helps providers make more informed treatment decisions and match patients to clinical trials.
12th Annual Personalized Medicine Conference
Convening just one week after the U.S. Presidential election, participants at the 12th Annual Personalized Medicine Conference began to identify potential solutions to ongoing challenges in regulation and reimbursement. The respective leaders of Joe Biden’s Cancer Moonshot Task Force and President Obama’s All of Us™ Research Program indicated that personalized medicine has bipartisan support in Congress, and the six payers who spoke at the event signaled a willingness to engage the community on the topic.
11th Annual Personalized Medicine Conference
Attendees at the 11th Annual Personalized Medicine Conference agreed on the need for collaborative initiatives to accelerate the pace of progress, and New England Patriots owner Robert Kraft acted on that need by announcing his decision to establish a $20 million endowment with the Harvard Business School during the event. Other highlights included the presentation of a “personalized medicine report card” from Duke University Chancellor Emeritus Ralph Snyderman, M.D., and a powerful discussion on innovation in personalized medicine led by Foundation Medicine CEO Michael Pellini, M.D., M.B.A.
10th Annual Personalized Medicine Conference
The 2014 Personalized Medicine Conference was held November 12 – 13, 2014. By all accounts from attendees, speakers and panelists, the event was a great success and continued to help push personalized medicine toward becoming the paradigm for the care of patients everywhere. Speakers included Margaret Hamburg, M.D., Commissioner, U.S. Food and Drug Administration; James Madara, M.D., Executive Vice President and CEO, American Medical Association; and Gary Gottlieb, M.D., President and CEO, Partners HealthCare System.
9th Annual Personalized Medicine Conference
The 9th Annual Personalized Medicine Conference, held November 6 – 7, 2013, was another successful, thought-provoking and engaging meeting. Speakers included Patrick Conway, M.D., Chief Medical Officer, U.S. Centers for Medicare & Medicaid Services; Cynthia Casson Morton, Ph.D., President, American Society of Human Genomics; and Margaret Foti, Ph.D., M.D., CEO of the American Association for Cancer Research.
8th Annual Personalized Medicine Conference
The 8th Annual Personalized Medicine Conference took place November 28 – 29, 2012. With more than 600 attendees, the two-day conference offered updates on personalized medicine and explanations of how recent experience may inform successful action plans in the future.
7th Annual Personalized Medicine Conference
The 7th Annual Personalized Medicine Conference was held November 9 – 10, 2011. The event continued conversations about the current status of the field, its opportunities for improving the health care of human populations without cost increases, and the obstacles that face the personalized medicine endeavor, providing a common forum for physicians, scientists, businesses, the investment community, payers, regulators, policymakers and the general public to discuss these issues in detail.
6th Annual Personalized Medicine Conference
The 6th Annual Personalized Medicine Conference was held November 17 – 18, 2010. The event engaged a diverse audience of national and international thought leaders in discussions to advance the understanding of and commitment to how the promise of personalized medicine is being and may continue to be fulfilled. The event focused attention on both achievements and challenges for the field.
5th Annual Personalized Medicine Conference
The 5th Annual Personalized Medicine Conference was held November 18 – 19, 2009. The two-day conference highlighted the current clinical impact of personalized medicine and explored how recent experiences could guide and inform the policies, plans, and actions of stakeholders in government, academia, and the private sector. The conference attracted national and international thought leaders.
4th Annual Personalized Medicine Conference
The 4th Annual Personalized Medicine Conference was held November 12 – 14, 2008. The event considered how the growing importance of personalized medicine should encourage all stakeholders to take appropriate steps to advance its implementation. Stellar presenters and panelists addressed many of the political, economic, and scientific issues that are influencing the pace at which personalized medicine is becoming a reality.
3rd Annual Personalized Medicine Conference
The 3rd Annual Personalized Medicine Conference, which reflected a distinctive collaboration between the Harvard Medical School, Partners HealthCare Center for Genetics and Genomics, and Harvard Business School, was held November 29 – 30, 2007. The event explored the opportunities for making personalized medicine a reality, addressing the integration of medicine and business in accelerating the adoption of personalized medicine by bringing together stakeholders, including leaders from pharmaceutical and diagnostics companies, medicine, academia, health care providers and payers, regulatory agencies, venture capitalists and the business community.
2nd Annual Personalized Medicine Conference
The 2nd Annual Personalized Medicine Conference, which reflected a distinctive collaboration between the Harvard Medical School, Partners HealthCare Center for Genetics and Genomics, and Harvard Business School, was held November 28 – 29, 2006. The event explored multiple perspectives about how the personalized medicine revolution has been put into practice and what is required on the part of physicians, patients, insurers, provider organizations, pharmaceutical innovators and the business community to ensure its future success.
1st Annual Personalized Medicine Conference
The first Personalized Medicine Conference was held November 3 – 4, 2005. The conference focused on the perspectives of government, pharmaceutical, academic, and diagnostic leaders, as well as those of health care providers and payers. The event was concentrated on five personalized medicine case studies on specific topics, such as lung cancer and cardiovascular disease. It also highlighted the information technology infrastructure needed to make personalized medicine a reality.